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Abstract: The resistance of pathogens to commonly used antibiotics has enhanced 
morbidity and mortality and has triggered the search for new drugs. Several species 
of the red alga genus Laurencia are very interesting candidates as potential sources 
of natural products with pharmaceutical activity because they are known to produce 
a wide range of chemically interesting halogenated secondary metabolites. This is 
an initial report of the antifungal activities of the secondary metabolites of five 
species of Laurencia, collected in the state of Espírito Santo, against three strains 
of pathogenic fungi: Candida albicans (CA), Candida parapsilosis (CP), and 
Cryptococcus neoformans (CN). Minimum inhibitory concentrations (MIC) of the 
algal extracts were determined by serial dilution method in RPMI 1640 Medium in 
96-well plates according to the NCCLS and microbial growth was determined by 
absorbance at 492nm. A result showing maintenance or reduction of the inoculum 
was defined as fungistatic, while fungicidal action was no observed growth in the 
10 µL fungistatic samples subcultured in Sabouraud Agar. Our results indicate that 
apolar extracts of Laurencia species possess antifungal properties and encourage 
continued research to find new drugs for therapy of infectious diseases in these 
algae. 
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Introduction
 Currently, multiple drug resistance of human 
pathogenic microorganisms is due to the indiscriminate 
use of the commercial antimicrobials commonly used 
for the treatment of infectious diseases (Karaman et 
al., 2003). The search for new, more specific and better 
adapted antimicrobial agents has been further stimulated 
by the occurrence of fatal opportunistic infections 
associated with AIDS, antineoplasic chemotherapy and 
transplants (Penna et al., 2001).
 As a consequence of the increasing demand 
for biodiversity in screening programs for potential 
therapeutic activities of natural products, there is an 
increased interest in marine fauna and flora throughout 
the world (Sasidharan et al., 2010). In this context, 
tropical marine algae have proven to be a rich source of 
bioactive compounds of potential biomedicinal interest 
(Sieburth, 1964; Burkholder, 1973; Caccamese et al., 
1981; Reichelt & Borowitzka, 1984; Robles-Centeno 
et al., 1996; Plaza et al., 2010).
 Brazil occupies a prominent position as 
an interesting source of natural products due to the 
richness of its biodiversity, including the red seaweed 
genus Laurencia (Fujii & Sentíes, 2005), which 
is known to produce numerous biologically active 
halogenated secondary metabolites with a diversity 
of structural features (Erickson, 1983), predominantly 
sesquiterpenes, diterpenes, and acetylenes (Blunt et al., 
2005). Many of these metabolites have been isolated 
and their structures determined, but their biological 
activity needs to be investigated in more detail (Ireland 
et al., 2000).
 There are numerous studies testing inhibition 
against bacteria, some viruses and marine fungi, but there 
are few studies of the activity of compounds or extracts 
of Laurencia against human pathogenic fungi. Ballantine 
et al. (1987) collected Laurencia obtusa (Huds.) J.V. 
Lamour., Yuzurua poiteaui (J.V. Lamour.) Martin-Lescanne 
(as Laurencia poitei) and Laurencia sp. from Puerto Rico 
and evaluated the antifungal properties of chloroform/
methanol (2:1) extracts against Candida albicans. The 
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L. obtusa extract showed a 0.5 mm inhibition using the 
disc-agar method.
 Most authors use agar diffusion assays to 
determine the antimicrobial activity of algal extracts. 
The technique works adequately with well-defined 
inhibitors (Hewitt & Vincent, 1989), but with extracts 
that contain unknown components there are problems 
with false positive and false negative results (Eloff, 
1998). The type of agar, the salt concentration, the 
incubation temperature, and the molecular size of 
the antimicrobial components can all influence the 
results obtained with agar diffusion assays (Marsh 
& Goode, 1994). Furthermore, this technique also 
cannot distinguish between fungicidal (the lowest 
concentration of the agent that results in no growth) 
and fungistatic (the lowest concentration of the agent 
that results in the maintenance or reduction of the 
inoculum) effects (Hammer et al., 2003) and does 
not permit determination of the minimum inhibitory 
concentration (MIC) (Eloff, 1998).
 The present study is an initial report of the 
results of screening assays for a variety of biological 
activities with extracts of Laurencia species, with the 
aim of identifying novel and interesting potentially 
useful therapeutic activities. In this paper, we describe 
the antifungal activities of extracts of five Laurencia 
species collected in the state of Espírito Santo, 
Southeastern Brazil, measured by using a sensitive and 
rapid serial dilution technique in 96-well microplates. 
Materials and Methods
Algae and preparation of the extracts 
 The red seaweeds Laurencia aldingensis 
Saito & Womersley (LA), Laurencia catarinensis 
Cord.-Mar. & M.T. Fujii (LC), Laurencia dendroidea 
J. Agardh (LD), Laurencia intricata J.V. Lamour. 
(LI) and Laurencia translucida M.T. Fujii & Cord.-
Mar. (LT) were collected in two counties of Espírito 
Santo State, Southeastern Brazil (Table 1). Vouchers of 
representative specimens were deposited in the Maria 
Eneyda P. Kauffmann Fidalgo Herbarium (SP) at the 
Instituto de Botânica in São Paulo. 
 After collection, the fresh algae were washed 
thoroughly with seawater, followed by fresh water 
to remove sand particles and epiphytes. The cleaned 
material was stored frozen at -20 oC until preparation 
of the extracts. For that purpose, approximately 30 
g of dried and powdered alga was added to 300 mL 
of hexane and allowed to soak overnight. To ensure 
complete extraction, this procedure was repeated 
on three subsequent days. The extract was filtered 
and concentrated on a rotary evaporator. The same 
procedure was repeated using chloroform, methanol 
and water, generating the hexane, chloroform, methanol 
and aqueous extracts. In addition, a crude water extract 
was prepared from 30 g of fresh alga in water to obtain 
a clean, non-toxic extract preparation that was then 
concentrated on a Speed Vac. The dried extracts were 
re-dissolved in 10% ethanol (by volume) or water to 
yield a solution containing 4 mg of extract per mL of 
growth medium.
Microorganisms
 The test organisms included three American 
Type Culture Collection (ATCC) fungal strains: Candida 
albicans ATCC 10231 (CA), Candida parapsilosis ATCC 
29212 (CP) and Cryptococcus neoformans ATCC 90112 
(CN). 
Antifungal Drug and microdilution tray
 Fluconazole was obtained as a reagent-grade 
powder from Sigma. Microdilution trays containing 
serial dilutions of the antifungal agent in RPMI 1640 
medium (Sigma) were prepared in a single lot and 
stored frozen at -20 °C until used in the study.
Broth microdilution assay
 Broth microdilution assays were performed 
according to National Committee for Clinical 
Laboratory Standards (NCCLS) for the establishment 
of quality control and referenced strain, using the 
methods (NCCLS, 2002) with minor modifications. 
 Yeast inocula were prepared by growing 
isolates on Sabouraud dextrose agar (SDA) for 24-48 h 
at 35 °C and then suspending growth in 5 mL of saline 
(0.145 mol.L-1) prepared in sterile distilled water. The 
optical density of this suspension was adjusted to 
0.5 McFarland standard turbidity in a Shimadzu UV-
1650 PC spectrophotometer (Kyoto, Japan) to obtain a 
concentration of 1 x 106 to 5 x 106 UFC.mL-1 and then 
diluted 1:100 followed by 1:20 in RPMI 1640 medium 
to obtain a final inoculum concentration of 5.0 x 102 to 
2.5 x 103 UFC.mL-1. Serial dilutions were prepared in 
96-well microplates with 50 µL of RPMI 1640 Medium 
in each well as described (Zgoda & Porter, 2001) with 
the following modifications. A 50 µL aliquot of initially 
prepared extract at the concentration of 4mg/ml was 
added into the first well. Then, 50 µL aliquots of the 
corresponding serial dilutions were transferred into six 
consecutive wells to obtain final concentrations ranging 
from 1,000 to 31.25 μg.mL-1 (50 µL). The last well 
contained just 50 µL of nutrient broth plus an aliquot 
of the extract vehicle (10% ethanol or water), used as 
the negative control. After serial dilution, 50 µL of the 
inoculum were added to the wells. The final volume 
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chloroform and methanol extracts of L. dendroidea were 
<31.25 µg.mL-1 against CA with a fungistatic effect; the 
chloroform extract of L. catarinensis showed the same 
results against CP. A fungistatic effect was observed 
for the methanol extract of L. aldingensis against CP 
(MIC<31.25 µg.mL-1), CN (33.9 µg.mL-1) and CA 
(65.2 µg.mL-1). The fungicidal effects of the hexane 
and chloroform extracts of L. aldingensis against CP 
were indicated by MIC values of 49.0 and 57.8 µg.mL-1, 
respectively; the same extracts were fungistatic agaist 
CA and CN between the concentrations of 85.3 and 
130.8 µg.mL-1. Moreover, the chlroform extract of 
L. catarinensis was fungicidal agaist CA and CN at 
303.8 and 600.4 µg.mL-1, respectively. Of all of the 
extracts of L. intricata, the chloroform extract was 
the most active, with a MIC higher than 220 µg.mL-1. 
The Laurencia translucida extracts showed no activity 
against CA, while between 177 and 743 µg.mL-1 were 
required to observe a fungistatic effect against CP or 
CN. Comparison of the three different fungal strains 
indicates that C. albicans was the most susceptible to 
maintenance or reduction of growth by the extracts, 
while C. parapsilosis was the most susceptible to the 
fungicidal effects of the algal extracts. L. aldingensis 
appears to be a particularly interesting alga, showing 
activity against all three fungal strains tested. 
 In general, the results show that the aqueous 
extracts stimulate cells growth, except for the crude 
water extracts of L. aldingensis and L. dendroidea, 
which show a reasonable percentage of inhibition (110 
µg.mL-1and 100 µg.mL-1, respectively) agaist CN.
 The MIC values of the positive control 
fluconazole were in agreement with those reported by 
NCCLS (MIC≤2 µg.mL-1) for the reference antifungal 
agent.
 Of the known algal secondary metabolites 
with biological activities, approximately 90% are lipid-
soluble (Norris & Fenical, 1985). The survey reported 
here was undertaken to assess the occurrence of lipid-
soluble bioactive materials in these macroalgal species 
and to evaluate them more thoroughly as sources of 
potentially useful bioactive substances.
 The present technique using 96-well microplates 
and spectrophotometric detection of the MIC was 
successfully applied to compare the antifungal activities 
of extracts from different species of Laurencia. The 
method is robust, inexpensive, relatively quick and 30-fold 
more sensitive than other methods commonly used in the 
literature; in addition, it requires only a small quantity of 
sample, can be applied to a large number of samples (very 
useful for screening), and provides a permanent record of 
the results (Ellof, 1998).
 The importance of investigating the activity of 
crude extracts lies in identifying promising candidates 
for additional investigation. In addition, the activity of 
in each well was 100 µL. Fluconazole was prepared in 
water at concentrations ranging from 64 to 2 μg.mL-1 
and used as the standard for the positive control. 
Spectrophotometric determination of the Minimum 
Inhibitory Concentration (MIC)
 For yeasts, the MIC value was determined 
as the lowest concentration of the extract in the broth 
medium that resulted in maintenance or reduction of the 
inoculum (Hammer et al., 2003). Spectrophotometric 
readings on each well were performed with a Tecan 
M200 automated plate reader (Männedorf, Switzerland) 
set at 492 nm after the well had been agitated. MIC 
endpoints were determined as the first concentration of 
the antifungal agent at which turbidity in the well was 
≥50% less than that in the control well (Pfaller et al., 
1995).
 
Determination of Concentration Effects (CE)
 The concentration effects were determined by 
subculturing 10 µL from each well of the microtiter 
tray that showed inhibition, carried out by spot 
inoculating onto SDA and incubating aerobically at 35 
°C. Any inoculum growth on agar plates corresponds 
to a fungistatic effect, while a fungicidal effect is 
characterized by no observed growth of the 10 µL 
fungistatic samples subcultured in Sabouraud Agar 
(Hammer et al, 2003). 
Statistical analysis
 The extract fractions were prepared in triplicate 
and measured for their antifungal activity, expressed as 
the percentage of activity (%AE) with the formula adapted 
from Felício et al. (2008): 
 
 Where AE represents the “absorbance of 
the test plates after the incubation time”; AEB is the 
“absorbance of plates containing medium, sample and 
inoculum at t=0 of incubation”; AC is the “absorbance 
of plates containing negative control (with or without 
vehicle) (100% of inoculum growth)”; and ACB is the 
“absorbance of plates containing culture medium”. 
All of the MIC values were calculated by nonlinear 
regression.
Results and discussion
 The data obtained by the microdilution 
technique are collected in Table 2. The MIC of the 
% AE = 100 - AE - AEB 
    AC - ACB 
x 100
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an extract may be due synergy between two or more 
components and other beneficial pharmacological or 
medicinal properties can be explored. For extracts that 
show activity, subsequent fractionation or isolation 
of the individual components is necessary to obtain 
an understanding of the activity of each individual 
component and of the contribution of each component 
to the overall activity of the extract as a whole. In 
conclusion, this study suggests that apolar extracts 
of several species of Laurencia possess interesting 
antifungal properties, which should encorage the 
continued search for new drugs for therapy of infectious 
diseases derived from marine algae.
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Table 1. List of the species used in the experiments, with 
collection information and voucher number.
Species Collection data Voucher
Laurencia aldingensis 
Saito & Womersley 
(LA)
Espírito Santo State, Anchieta, 
Praia dos Castelhanos, col. 
E.M. Stein, 01 Jul. 2007 
SP 399.933
Laurencia catarinensis 
Cord.-Mar. & M.T. 
Fujii (LC)
Espírito Santo State, Anchieta, 
Praia dos Castelhanos, col. 
E.M. Stein, 01 Jul. 2007
SP 400.209
Laurencia dendroidea 
J. Agardh (LD)
Espírito Santo State, 
Anchieta, Praia de Parati, col. 
E.M. Stein, 30 Jun. 2007 
SP 400.198
Laurencia intricata 
J.V.Lamour. (LI)
Espírito Santo State, 
Guarapari, Praia de Meaípe, 
col. E.M. Stein, 09 Apr. 2009
SP 400.207
Laurencia translucida 
M.T. Fujii & Cord.-
Mar. (LT)
Espírito Santo State, Anchieta, 
Praia dos Castelhanos, col. 
E.M. Stein, 09 Apr. 2009 
SP 400.830
Table 2. Spectrophotometric Minimal Inhibitory Concentration endpoints (≤50% less than that in the control well), expressed in 
µg/mL, of Laurencia aldingensis, L. catarinensis, L. intricata, L. dendroidea, L. translucida extracts against the reference strains 
Candida albicans, Candida parapsilosis, Cryptococcus neoformans. End points were measured at 492 nm.
Extract
C. albicans C. parapsilosis C. neoformans 
(ATCC 10231) (ATCC 29212) (ATCC 90112)
LA-HE
MIC 100.6 49.0 130.8 
Concentration effect Fungistatic Fungicidal Fungistatic
LA-CE
MIC  85.3 57.8  100.2 
Concentration effect Fungistatic Fungicidal Fungistatic
LA-ME
MIC 65.2 <31.25 33.9
Concentration effect Fungistatic Fungistatic Fungistatic
LA-AE
MIC n.d n.d. n.d.
Concentration effect - - -
LA-CW MIC n.d n.d. 110.0
Concentration effect - - Fungistatic
LC-HE
MIC n.d. 403.4 n.d.
Concentration effect - Fungistatic -
LC-CE
MIC 303.8 < 31.25 600.4
Concentration effect Fungicidal Fungistatic Fungicidal
LC-ME
MIC n.d n.d. n.d.
Concentration effect - - -
LC-AE
MIC n.d n.d. n.d.
Concentration effect - - -
LD-HE
MIC 183.6 812.50 542.1
Concentration effect Fungistatic Fungistatic Fungistatic
LD-CE
MIC <31.25 176.6 176.0
Concentration effect Fungistatic Fungistatic Fungistatic
LD-ME
MIC < 31.25 n.d. 159.0
Concentration effect Fungistatic - Fungistatic
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